|
|
Blood, 1 May 2006, Vol. 107, No. 9, pp. 3555-3563.
Prepublished online as a Blood First Edition Paper on January 3, 2006; DOI 10.1182/blood-2005-10-4168.
 Previous Article | Table of Contents | Next Article 
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
Enhancement of thrombogenesis by plasma fibronectin cross-linked to fibrin and assembled in platelet thrombi
Jaehyung Cho, and
Deane F. Mosher
From the Molecular and Cellular Pharmacology Program and Department of Medicine, University of Wisconsin-Madison School of Medicine, Madison, WI.
To learn how plasma fibronectin stabilizes platelet-rich thrombi in injured mesenteric arterioles of mice, we studied the impact of plasma fibronectin on platelet thrombus formation ex vivo in a parallel flow chamber. Thrombi were greater on surfaces coated with fibrin cross-linked to fibronectin by activated factor XIII than on surfaces coated with fibrin lacking cross-linked fibronectin or with fibronectin alone. Platelet thrombi were even greater when plasma fibronectin was perfused with platelets, resulting in deposition of the perfused fibronectin in platelet thrombi. The effect of perfused fibronectin on thrombogenesis was lost if fibronectin deposition was blocked by coperfusion with the N-terminal 70-kDa fragment of fibronectin or a peptide based on the functional upstream domain of protein F1 of Streptococcus pyogenes. Increases in thrombus formation were dependent on a platelet activator such as lysophosphatidic acid, amount of fibronectin cross-linked to fibrin, and concentration of fibronectin in the perfusate. The dependency of fibronectin concentration extended into the range of fibronectin concentrations associated with increased risk of coronary artery disease. At such concentrations, the 2 mechanisms for insolubilization of plasma fibronectin—cross-linking to fibrin and assembly by adherent and aggregating platelets—synergize to result in many-fold enhancement of platelet thrombus formation.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
Related Article in Blood Online:
-
Fibronectin comes to the fore in thrombus growth
- John W. Weisel
Blood 2006 107: 3419-3420.
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
D. F. Mosher
Adding Complexity to Fibronectin-Platelet Interactions
Arterioscler. Thromb. Vasc. Biol.,
February 1, 2008;
28(2):
203 - 204.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. K. Chauhan, J. Kisucka, M. R. Cozzi, M. T. Walsh, F. A. Moretti, M. Battiston, M. Mazzucato, L. De Marco, F. E. Baralle, D. D. Wagner, et al.
Prothrombotic Effects of Fibronectin Isoforms Containing the EDA Domain
Arterioscler. Thromb. Vasc. Biol.,
February 1, 2008;
28(2):
296 - 301.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. P. Jackson
The growing complexity of platelet aggregation
Blood,
June 15, 2007;
109(12):
5087 - 5095.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. R. Barthel, D. S. Annis, D. F. Mosher, and M. W. Johansson
Differential Engagement of Modules 1 and 4 of Vascular Cell Adhesion Molecule-1 (CD106) by Integrins {alpha}4beta1 (CD49d/29) and {alpha}Mbeta2 (CD11b/18) of Eosinophils
J. Biol. Chem.,
October 27, 2006;
281(43):
32175 - 32187.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Cho and D. F. Mosher
Impact of fibronectin assembly on platelet thrombus formation in response to type I collagen and von Willebrand factor
Blood,
October 1, 2006;
108(7):
2229 - 2236.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. F. Mosher
Plasma Fibronectin Concentration: A Risk Factor for Arterial Thrombosis?
Arterioscler. Thromb. Vasc. Biol.,
June 1, 2006;
26(6):
1193 - 1195.
[Full Text]
[PDF]
|
|
|
| |
